Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized trial of CZ1S infiltration for post–total hip arthroplasty analgesia
CTR20243821Phase 2Active
- Sponsor
- Zhejiang Cuize Pharmaceutical Technology
- Start
- Nov 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of CZ1S in postoperative pain, sponsored by Zhejiang Cuize Pharmaceutical Technology. Started Nov 2024; status: active.
02
Drugs
CZ1S
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20243821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243821.